ABT-494 PHARMACOKINETICS FOLLOWING ADMINISTRATION OF THE ONCE-DAILY EXTENDED-RELEASE TABLET FORMULATION BEING UTILIZED IN THE ONGOING RHEUMATOID ARTHRITIS PHASE 3 TRIALS

被引：2
|
作者：
Mohamed, M. -E. F. [1 ]
Zeng, J. [1 ]
Song, I. -H. [2 ]
Othman, A. A. [1 ]
机构：
[1] AbbVie, Clin Pharmacol & Pharmacometr, N Chicago, IL USA
[2] AbbVie, Immunol Clin Dev, N Chicago, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0177
引用
收藏
页码：268 / 269
页数：2
相关论文
共 30 条
  • [1] Pharmacokinetics of ABT-494 with the Once-Daily Extended-Release Tablet Formulation Being Utilized in the Ongoing Rheumatoid Arthritis Phase 3 Trials
    Mohamed, Mohamed-Eslam
    Zeng, Jiewei
    Song, In-Ho
    Othman, Ahmed A.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended-Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials
    Mohamed, Mohamed-Eslam F.
    Zeng, Jiewei
    Marroum, Patrick J.
    Song, In-Ho
    Othman, Ahmed A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (02): : 208 - 216
  • [3] Effexor XR - Extended-release capsule formulation for once-daily administration
    不详
    FORMULARY, 1998, 33 (02) : 99 - 99
  • [4] ABT-494 HAS NO EFFECT ON THE QT INTERVAL AT THE DOSES BEING EVALUATED IN RHEUMATOID ARTHRITIS PHASE 3 TRIALS
    Mohamed, M-E. F.
    Zeng, J.
    Jiang, P.
    Hosmane, B.
    Othman, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1201 - 1201
  • [5] POPULATION PHARMACOKINETICS OF ABT-494 IN HEALTHY SUBJECTS AND IN SUBJECTS WITH RHEUMATOID ARTHRITIS: COMBINED ANALYSIS OF PHASE I AND II TRIALS
    Kluender, B.
    Mohamed, M. -E. F.
    Othman, A. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S79 - S79
  • [6] Design and in vitro evaluation of an extended-release matrix tablet for once-daily oral administration of oxybutynin
    Zambito, Y
    Baggiani, A
    Carelli, V
    Serafini, MF
    Di Colo, G
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2005, 15 (05) : 397 - 402
  • [7] Pharmacokinetics of a Once-Daily Extended-Release Formulation of Pramipexole in Healthy Male Volunteers: Three Studies
    Jenner, Peter
    Koenen-Bergmann, Michael
    Schepers, Cornelia
    Haertter, Sebastian
    CLINICAL THERAPEUTICS, 2009, 31 (11) : 2698 - 2711
  • [8] Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation
    Huang, YB
    Tsai, YH
    Yang, WC
    Chang, JS
    Wu, PC
    Takayama, K
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (03) : 607 - 614
  • [9] Comparative Pharmacokinetics of a Once-Daily Tramadol Extended-Release Tablet and an Immediate-Release Reference Product Following Single-Dose and Multiple-Dose Administration
    Karhu, David
    Fradette, Caroline
    Potgieter, Maria Alida
    Ferreira, Maria M.
    Terblanche, Johann
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (05): : 544 - 553
  • [10] Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food
    Lamba, Manisha
    Wang, Rong
    Fletcher, Tracey
    Alvey, Christine
    Kushner, Joseph
    Stock, Thomas C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (11): : 1362 - 1371
123